Transforming growth factor-1 in children with diabetic nephropathy

被引:7
|
作者
Sawires, Happy [1 ]
Botrous, Osama [2 ]
Aboulmagd, Abdelmegeed [2 ]
Madani, Nadia [3 ]
Abdelhaleem, Osama [4 ]
机构
[1] Cairo Univ, Pediat Nephrol & Transplantat Ctr, Cairo, Egypt
[2] Beni Suef Univ, Pediat Dept, Bani Suwayf, Egypt
[3] Cairo Univ, Microbiol Dept, Giza, Egypt
[4] Beni Suef Gen Hosp, Pediat Dept, Minist Hlth, Bani Suwayf, Egypt
关键词
Transforming growth factor; Type; 1; diabetes; Children; Diabetic nephropathy; Microalbuminuria; FACTOR-BETA; GENE-EXPRESSION; TGF-BETA; GROWTH-FACTOR-BETA-1; FACTOR-BETA(1); ACTIVATION; MELLITUS; GLUCOSE; PROTEIN; ONSET;
D O I
10.1007/s00467-018-4062-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundTransforming growth factor-1 (TGF-1) is a multifunctional cytokine that has numerous biological processes. Earlier research indicates that protein and mRNA production of TGF-1 are enhanced in the renal tissues of patients with diabetic nephropathy (DN). Our aim was to evaluate the role of TGF-1 in early prediction of DN in children with type 1 diabetes mellitus (T1DM).MethodsFifty patients with T1DM were enrolled in an observational study. Patients were eligible to participate if at least 3 years had passed since T1DM diagnosis. Patients were classified into two groups (A and B) according to the presence or absence of microalbuminuria, respectively. Serum TGF-1 was measured by ELISA in the patients.ResultsOut of the 50 studied patients with T1DM, there were 23 (46%) patients with microalbuminuria. There was a significant difference between patients in group A and B as regards TGF-1 (p<0.001). HbA1c had very little influence in controlling for the relationship between TGF-1 and disease duration. Diagnostic cutoff value of TGF-1 was 358.5pg/ml with sensitivity and specificity of 100%.ConclusionTGF-1 was significantly higher in children with DN in comparison with children without. It could be used as an early indicator of DN in children with T1DM with high sensitivity and specificity.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 50 条
  • [1] Transforming growth factor-β1 in children with diabetic nephropathy
    Happy Sawires
    Osama Botrous
    Abdelmegeed Aboulmagd
    Nadia Madani
    Osama Abdelhaleem
    Pediatric Nephrology, 2019, 34 : 81 - 85
  • [2] Transforming growth factor-β1 and diabetic nephropathy
    Chang, Albert S.
    Hathaway, Catherine K.
    Smithies, Oliver
    Kakoki, Masao
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (08) : F689 - F696
  • [3] Relationship between transforming growth factor-1 and type 2 diabetic nephropathy risk in Chinese population
    Zhou, Tianbiao
    Li, Hong-Yan
    Zhong, Hongzhen
    Zhong, Zhiqing
    BMC MEDICAL GENETICS, 2018, 19
  • [4] Transforming growth factor-β in diabetic nephropathy
    Karima Y. Ahmed
    Walaa F. El-Bazz
    Hend A. Mohamed
    Maha M. Elkeshky
    The Egyptian Journal of Internal Medicine, 2013, 25 (1) : 20 - 26
  • [5] Transforming growth factor beta in diabetic nephropathy
    Border, WA
    Yamamoto, T
    Noble, NA
    DIABETES-METABOLISM REVIEWS, 1996, 12 (04): : 309 - 339
  • [6] Hepatocyte growth factor and transforming growth factor-β1 balance in experimental diabetic nephropathy
    Cruzado, JM
    Lloberas, N
    Torras, J
    Riera, M
    Fillat, C
    Herrero, D
    Aran, JM
    Castelao, AM
    Grinyo, JM
    DIABETES, 2002, 51 : A181 - A181
  • [7] Transforming growth factor β contributes to progressive diabetic nephropathy
    Reeves, WB
    Andreoli, TE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) : 7667 - 7669
  • [8] Transforming growth factor-β1 in IDDM patients with and without diabetic nephropathy
    Korpinen, E
    Groop, PH
    Fagerudd, J
    Teppo, AM
    Åkerblom, HK
    Vaarala, O
    DIABETOLOGIA, 1998, 41 : A39 - A39
  • [9] Regulation of transforming growth factor β in diabetic nephropathy:: Implications for treatment
    Zhu, Yonqing
    Usui, Hitomi Kataoka
    Sharma, Kumar
    SEMINARS IN NEPHROLOGY, 2007, 27 (02) : 153 - 160
  • [10] Transforming growth factor-β/Smad signalling in diabetic nephropathy
    Lan, Hui Yao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2012, 39 (08): : 731 - 738